$KTOV $LLY $MRK What stands out to me is the Phase 2 study in combo with Cetuximab and the mention of US and Canada based studies. This points to Phase 2 Collab with Eli Lilly who owns right to Cetuximab in the US and Canada and Merck owns the right in all other parts of the world.